Commercial Services Healthcare Sector

Galectin Therapeutics

Market Cap: US$81.0m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

I-Mab

Market Cap: US$80.8m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

SomnoMed

Market Cap: AU$124.3m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

Anixa Biosciences

Market Cap: US$80.5m

A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.

Climb Bio

Market Cap: US$79.7m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

IO Biotech

Market Cap: US$79.7m

A clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.

Paradigm Biopharmaceuticals

Market Cap: AU$122.7m

Engages in the research and development of therapeutic products for human use in Australia.

Champions Oncology

Market Cap: US$79.5m

A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.

NetraMark Holdings

Market Cap: CA$109.0m

Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.

Pliant Therapeutics

Market Cap: US$79.2m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Quipt Home Medical

Market Cap: CA$107.7m

Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.

Planet 13 Holdings

Market Cap: CA$107.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

TScan Therapeutics

Market Cap: US$78.1m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Milestone Scientific

Market Cap: US$78.1m

A biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

Sutro Biopharma

Market Cap: US$77.7m

Operates as a oncology company.

InspireMD

Market Cap: US$77.5m

A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.

Sensus Healthcare

Market Cap: US$77.1m

Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Genenta Science

Market Cap: US$76.8m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Kooth

Market Cap: UK£56.5m

Provides digital mental health services to children, young people, and adults in the United Kingdom.

Pyxis Oncology

Market Cap: US$76.2m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

4DMedical

Market Cap: AU$117.1m

Operates as a medical technology company in the United States and Australia.

Cumberland Pharmaceuticals

Market Cap: US$76.0m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

e-therapeutics

Market Cap: US$76.0m

Engages in drug discovery research activities in the United Kingdom.

IGM Biosciences

Market Cap: US$75.1m

A biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

ESSA Pharma

Market Cap: US$75.0m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Adaptimmune Therapeutics

Market Cap: US$74.2m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

CervoMed

Market Cap: US$73.7m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Veru

Market Cap: US$73.1m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Inotiv

Market Cap: US$72.8m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Nuo Therapeutics

Market Cap: US$72.5m

Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

Zynex

Market Cap: US$72.3m

Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Inovio Pharmaceuticals

Market Cap: US$72.2m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

TRUBAR

Market Cap: CA$98.7m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

PDS Biotechnology

Market Cap: US$71.7m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Jasper Therapeutics

Market Cap: US$71.7m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

Syntara

Market Cap: AU$108.8m

Operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia.